Impact of Glycation on Antibody Clearance

Glycation of therapeutic proteins occurs during mammalian cell culture expression and upon administration to patients. Since the chemical attachment of mannose or other sugars via a chemical linker has been shown to increase a protein’s clearance rate in mice through the mannose receptor, we explored the effect of mannose glycation on the clearance of an IgG in mice. An IgG decorated with high levels of mannose (~18 mol/mol protein) through glycation did not clear faster in mice than the underivatized protein, whereas the same IgG decorated with mannose attached in a way to maintain the normal glycosidic bond (2-imino-2-methoxyethyl-1-thiomannoside, or IMT-mannose) at similar derivatization levels cleared significantly faster. Surface plasmon resonance studies revealed that the IgG derivatized with IMT-mannose bound tightly to the mannose receptor (KD = 20 nM) but the IgG glycated with mannose did not bind. These results indicate that glycation, even at unnaturally elevated levels, does not appear to be a clearance concern for therapeutic proteins.

[1]  M. Joubert,et al.  Use of In Vitro Assays to Assess Immunogenicity Risk of Antibody-Based Biotherapeutics , 2016, PloS one.

[2]  Andrew M Goetze,et al.  Rates and impact of human antibody glycation in vivo. , 2012, Glycobiology.

[3]  U. Rova,et al.  Pichia pastoris-produced mucin-type fusion proteins with multivalent O-glycan substitution as targeting molecules for mannose-specific receptors of the immune system. , 2011, Glycobiology.

[4]  P. Bondarenko,et al.  High-mannose glycans on the Fc region of therapeutic IgG antibodies increase serum clearance in humans. , 2011, Glycobiology.

[5]  D. Hambly,et al.  Characterization of site-specific glycation during process development of a human therapeutic monoclonal antibody. , 2011, Journal of pharmaceutical sciences.

[6]  Xiaoyu Chen,et al.  Gas-phase oligosaccharide nonreducing end (GONE) sequencing and structural analysis by reversed phase hplc/mass spectrometry with polarity switching , 2009, Journal of the American Society for Mass Spectrometry.

[7]  Inn Yuk,et al.  Unveiling a glycation hot spot in a recombinant humanized monoclonal antibody. , 2008, Analytical chemistry.

[8]  O. Llorca.  Extended and bent conformations of the mannose receptor family , 2008, Cellular and Molecular Life Sciences.

[9]  Brian Hubbard,et al.  Downstream processing of monoclonal antibodies--application of platform approaches. , 2007, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[10]  Joop A. Peters,et al.  The structure of the sugar residue in glycated human serum albumin and its molecular recognition by phenylboronate. , 2003, Chemistry.

[11]  C. Isacke,et al.  The mannose receptor family. , 2002, Biochimica et biophysica acta.

[12]  M. Nussenzweig,et al.  Mannose Receptor-Mediated Regulation of Serum Glycoprotein Homeostasis , 2002, Science.

[13]  M. Hashida,et al.  In vivo recognition of mannosylated proteins by hepatic mannose receptors and mannan-binding protein. , 2001, American journal of physiology. Gastrointestinal and liver physiology.

[14]  W. Weis,et al.  Structure of a C-type Carbohydrate Recognition Domain from the Macrophage Mannose Receptor* , 2000, The Journal of Biological Chemistry.

[15]  S. Gordon,et al.  Mannose Receptor and Its Putative Ligands in Normal Murine Lymphoid and Nonlymphoid Organs: In Situ Expression of Mannose Receptor by Selected Macrophages, Endothelial Cells, Perivascular Microglia, and Mesangial Cells, but not Dendritic Cells , 1999, The Journal of experimental medicine.

[16]  Andrew N. Rowan.  Guide for the Care and Use of Laboratory Animals , 1996 .

[17]  D. M. Kennedy,et al.  Glycation increases the vascular clearance rate of IgG in mice , 1993, Clinical and experimental immunology.

[18]  M. Taylor,et al.  Contribution to ligand binding by multiple carbohydrate-recognition domains in the macrophage mannose receptor. , 1992, The Journal of biological chemistry.

[19]  L. Morin,et al.  Non-enzymic glycation of individual plasma proteins in normoglycemic and hyperglycemic patients. , 1987, Clinical chemistry.

[20]  J. Baynes,et al.  13C NMR investigation of nonenzymatic glucosylation of protein. Model studies using RNase A. , 1983, The Journal of biological chemistry.

[21]  M. Krantz,et al.  2-Imino-2-methoxyethyl 1-thioglycosides: new reagents for attaching sugars to proteins. , 1976, Biochemistry.

[22]  A. Cerami,et al.  Correlation of glucose regulation and hemoglobin AIc in diabetes mellitus. , 1976, The New England journal of medicine.

[23]  R. Bucala,et al.  Advanced glycosylation: chemistry, biology, and implications for diabetes and aging. , 1992, Advances in pharmacology.